Soleus Capital Management, L.P. Novo Cure LTD Transaction History

Soleus Capital Management, L.P.

$1.18 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $6.94 Million - $14.1 Million	-586,859 Reduced 84.35%	108,900 $1.87 Million
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $4.9 Million - $6.83 Million	394,759 Added 131.15%	695,759 $10.9 Million
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $479,703 - $680,118	-43,100 Reduced 12.53%	301,000 $4.49 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $1.6 Million - $4.19 Million	99,000 Added 40.39%	344,100 $5.56 Million
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $4.64 Million - $9.5 Million	115,100 Added 88.54%	245,100 $10.2 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $7.34 Million - $15.4 Million	130,000 New	130,000 $7.82 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $226,400 - $359,600	-4,000 Reduced 23.15%	13,275 $923,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $300,750 - $422,600	-5,000 Reduced 22.45%	17,275 $1.43 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $375,400 - $609,950	-5,000 Reduced 18.33%	22,275 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $8.33 Million - $13.9 Million	-71,700 Reduced 72.44%	27,275 $3.17 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $9.6 Million - $16.6 Million	73,650 Added 290.82%	98,975 $22 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $40,459 - $61,995	326 Added 1.3%	25,325 $3.35 Million
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $3.07 Million - $4.77 Million	-27,378 Reduced 52.27%	24,999 $4.33 Million
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $233,361 - $447,466	-4,020 Reduced 7.13%	52,377 $5.83 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $2.91 Million - $3.78 Million	50,800 Added 907.63%	56,397 $3.34 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $319,308 - $535,912	5,597 New	5,597 $377,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account